Skip to main content

SteadyMD

By Jessica Hagen | 12:23 pm | May 05, 2023
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
By Emily Olsen | 12:49 pm | June 22, 2022
SteadyMD announced a $25 million Series B raise in March 2021.
By MobiHealthNews | 04:06 pm | March 30, 2021
Also: SteadyMD lands $25M for telemedicine platform and Lifelink System closes Series A round. 
By Dave Muoio | 12:25 pm | April 06, 2020
The raise will help SteadyMD further develop its technology platform and online services.
By Laura Lovett | 05:08 pm | March 23, 2018
Primary care concierge platform SteadyMD just announced that it secured $2.